On Sunday, a news came for COVID-19 that Ireland temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution”. This citing reports from the Norwegian Medicines Agency regarding a cluster of serious blood clotting in some recipients there. For your information let us share that health authorities said on Saturday that three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets,

For your information let us share that Ireland’s National Immunisation Advisory Committee (NIAC) recommended the temporary deferral pending the receipt of more information from European regulators in the coming days. Authorities in Denmark, Norway and Iceland have suspended the use of the vaccine over clotting issues, while Austria stopped using a batch of AstraZeneca shots last week while investigating a death from coagulation disorders.

However, it is to be noted that Irish authorities received some reports of clotting similar to those seen in Europe last week but nothing as serious as the cases in Norway, Deputy Chief Medical Officer Ronan Glynn said.  AstraZeneca vaccinations make up 20% of the 590,000 shots administered among Ireland’s 4.9 million population, mainly to healthcare workers after its use was not initially recommended for those over 70 and the firm supplied far fewer vaccines to the European Union than agreed. There have been 4,534 COVID-19-related deaths in Ireland. The number of cases per 100,000 people in the past 14 days fell to 155 from a high of over 1,500 in January, although officials are concerned over a slight rise in new cases in recent days.

World Consumer Rights Day- March 15

British Airways will launch its own digital “vaccine passport” in May

Myanmar : 38 people killed , martial law to imposed

‘No doubt’ there would be further wave of Covid-19 in the autumn, Says statistics chief